Jefferies Group's ARWR Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 4,994 shares of Arrowhead Pharmaceuticals, Inc. (ARWR) worth $407,061, representing 0.00% of the portfolio. First purchased in 2024-Q4, this short-term holding has been held for 3 quarters.
Based on 13F filings, Jefferies Group has maintained this position in ARWR for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2026, adding 4,994 shares. Largest reduction occurred in Q1 2025, reducing 8,012 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Arrowhead Pharmaceuticals (ARWR) Holding Value Over Time
Track share changes against reported price movement
Quarterly Arrowhead Pharmaceuticals (ARWR) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +4,994 | New Buy | 4,994 | $81.51 |
| Q1 2025 | -8,012 | Sold Out | 0 | $0.00 |
| Q4 2024 | +8,012 | New Buy | 8,012 | $18.80 |
Jefferies Group's Arrowhead Pharmaceuticals Investment FAQs
Jefferies Group first purchased Arrowhead Pharmaceuticals, Inc. (ARWR) in Q4 2024, acquiring 8,012 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Arrowhead Pharmaceuticals, Inc. (ARWR) for 3 quarters since Q4 2024.
Jefferies Group's largest addition to Arrowhead Pharmaceuticals, Inc. (ARWR) was in Q4 2024, adding 8,012 shares worth $150,626.
According to the latest 13F filing for Q2 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 4,994 shares of Arrowhead Pharmaceuticals, Inc. (ARWR), valued at approximately $407,061.
As of the Q2 2026 filing, Arrowhead Pharmaceuticals, Inc. (ARWR) represents approximately 0.00% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Arrowhead Pharmaceuticals, Inc. (ARWR) was 8,012 shares, as reported at the end of Q4 2024.